April 2015





View the E-Dition

Editor's Message

Investment and Innovation

Washington Medical Matters

Bringing an Ophthalmic Device to Market

Is it now easier in the United States than in Europe?

By Mark S. Talary, PhD, and Yijun Huang, PhD

Young Investigators

A Sticky Situation: The Effect of the Vitreomacular Interface on Neovascular AMD Treatment

By S. K. Steven Houston III, MD; Nadim Rayess, MD; Carl D. Regillo, MD; and Allen C. Ho, MD

The Road to Recertification

Controversy in Maintenance of Certification Requirements

Retina specialists should understand why some physicians favor the new MOC requirements and others oppose them.

By Diana V. Do, MD

Journal Club Update

Journal Club Update

From the Editors of New Retina MD

Cover Story

Venture Investing in Ophthalmology and Retina

An Interview with Emmett Cunningham, MD, PhD, MPH

Clinical Trials

Clinical Trials 101

Researchers must have a thorough understanding of the clinical trial process before they begin going down the long road of bringing a drug or device to market.

By Aron Shapiro

The First 5 Years

Evaluating A Partnership Contract

By Allen Chiang, MD

Practice Highlights

Vertical Integration: The Benefits of Working in a Multispecialty Practice

Job seekers should consider the benefits of an integrated practice model.

By John D. Pitcher III, MD

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Michael Jones
Senior Editor

Janet Burk

About New Retina MD

New Retina MD delivers cutting-edge content to retina specialists in their first 15 years of practice. Each issue provides fresh insight from younger physicians plus established mentors on clinical and nonclinical issues affecting ophthalmologists in the earlier stages of their careers. NRMD features surgical pearls, clinical research endeavors, practice management, medical reimbursement and policy, continuing educational requirements, financial planning, innovations, and more.